Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 19 of 35
Goals for Reaching Optimum Wellness (GROWell)
NCT02904473
Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery
NCT02829944
Brief Mood Enhancement Intervention
NCT02954965
ICAN Symptoms Duke-NUS
NCT02787993
CTC Immune Checkpoint
NCT02456571
Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking
NCT02995915
The Feasibility and Efficacy of an Extremely Brief Mindfulness Practice
NCT02953444
Addressing Barriers to Adult Hearing Healthcare
NCT02928107
Coherence Imaging of the Cervical Epithelium
NCT02903394
Pompe Disease QMUS and EIM
NCT02742298
Virtual vs. Traditional Physical Therapy Following Total Knee Replacement
NCT02914210
The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort
NCT02838108
Pediatric Obesity Observational Prospective Trial
NCT03139877
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
NCT02783170
Pediatric Metabolism and Microbiome Repository
NCT02959034
Study on Sit to Quit Phone Intervention
NCT02840435
Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program
NCT02845687
Using TMS to Increase Executive Function in Older Adults
NCT02767323
Stress-Delta Biomarkers for Acute Coronary Syndrome Risk Stratification
NCT02717702
ICanSTEP : Increasing Physical Activity With Text Messaging
NCT02627079
Patient-Empowered Mobile Technology in Hospitalized Patients (TRU-PAIN)
NCT02895841
Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)
NCT02722395
Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD
NCT02897362
Ventral Tegmental Area (VTA) Self-Activation in Attention Deficit Hyperactivity Disorder (ADHD)
NCT02723708
Mobile Contingency Management for Marijuana and Tobacco Cessation
NCT02869451
Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration
NCT02725710
Pokemon Go and Physical Activity
NCT02888314
Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers
NCT02848586
Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD)
NCT02813447
Cognitive Effects of Body Temperature During Hypothermic Circulatory Arrest
NCT02834065
Analyzing Retinal Microanatomy in ROP
NCT02887157
Quality of Life in Patients With Primary Sclerosing Cholangitis
NCT02712736
Pain Coping Skills for Colorectal Cancer Survivors
NCT02706301
Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF)
NCT02827500
Educational Videos to Address Racial Disparities in Implantable Cardioverter Defibrillator Therapy
NCT02819973
Effect of Urethral Analgesia on Voiding
NCT02823431
Point of Care 3D Ultrasound for Various Applications: A Pilot Study
NCT02831556
PrEP SMART Phase I Trial
NCT02895893
Diagnostic Utility of MRI in Female Patients With Nipple Discharge: A Prospective Trial
NCT02818946
Provider-Patient Communication Coaching
NCT02783742
Multi-Drug Resistant Organism Network
NCT03646227
CALYPSO Pilot Study: Machine Learning Based Predictions of Surgical Complications
NCT02828475
Families on Track: A Digital Health Behavioral Intervention for Parents Seeking Treatment for Their Child With Obesity
NCT02767440
A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers
NCT02824328
Adaptive Optics for Ophthalmic Technologies
NCT02826655
Effectiveness of ROTEM-based Coagulation Surveillance on Reducing Blood Product Utilization During Complex Spine Surgery
NCT02758184
Identification of Tongue Involvement in Late-Onset Pompe Disease
NCT02765828
Recruiting African American Fathers/ Sons
NCT02811848
A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia
NCT02619604
A mHealth Behavioral Cancer Pain Protocol for Medically Underserved Communities
NCT02783755
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.